NEWS
-
News & Events
- Sound Wave Innovation Co., Ltd. and Sparkling Photon, Inc. agree on a Business Alliance Memorandum of Understanding
- March 3, 2026
- The baseline paper of the LIPUS-AD study was published online in the Journal of Alzheimer’s Disease Reports (Dec 29th, 2025).
- January 5, 2026
- Sound Wave Innovation Wins Top Prize at Japan Healthcare Venture Summit 2025 Hosted by MHLW
- October 14, 2025
-
Papers & Conferences
- The baseline paper of the LIPUS-AD study was published online in the Journal of Alzheimer’s Disease Reports (Dec 29th, 2025).
- January 5, 2026
-
Media
- Sound Wave Innovation and Sumitomo Heavy Industries’ Strategic Partnership Featured in The Wall Street Journal
- September 26, 2025
-
Press Releases
- Sound Wave Innovation Co., Ltd. and Sparkling Photon, Inc. agree on a Business Alliance Memorandum of Understanding
- March 3, 2026
- Sound Wave Innovation and Sumitomo Heavy Industries Announce Strategic Partnership to Revolutionize Alzheimer’s Disease Treatment with LIPUS-Brain Device
- September 5, 2025
- Sound Wave Innovation Announces New Leadership to Ensure the Deployment of Dementia Treatment
- April 1, 2025
COMPANY
Our target is to make our innovative medical devices spreading all over the world and provide better therapies for patients.
Technical Information
-
LIPUS
The molecular mechanisms of the LIPUS therapy include mechano-transduction mediated by β1-integrin/caveolin-1 with resultant upregulation of endothelial NO synthase(eNOs) and vascular endothelial growth factor(VEGF). It enhances angiogenesis in ischemic tissue and induces spontaneous improvement of microcirculatory disorder for both severe angina and mild dementia. Two pipelines are in clinical study.
-
SWCS
Comparing to the ablation catheter that has been used for the treatment of arrhythmia, SWCS could treat deeper Arrhythmia source with less surface / peripheral tissues damage and less Thrombus formation.